Carbamic Acid

Carbamic Acid

SCHEMBL27675440

NC(=O)O.O=S(=O)(c1ccc(Oc2ccc(O)cc2)cc1)N1CCc2ccccc2C1

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 7/20 0.62
MEN1 O00255 2/20 0.61
KMT2A Q03164 2/20 0.61
ESR2 Q92731 1/20 0.59
SMN1; SMN2 Q16637 5/20 0.56
ALDH1A1 P00352 4/20 0.56
MAPT P10636 2/20 0.56
KDM4E B2RXH2 1/20 0.56
GAA P10253 3/20 0.54
CYP3A4 P08684 1/20 0.53
CYP2C19 P33261 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
AKR1C1 Q04828 1/20 0.53
TSHR P16473 2/20 0.52
LMNA P02545 2/20 0.49
MAPK1 P28482 1/20 0.49
USP2 O75604 1/20 0.47
HPGD P15428 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Carbamic Acid SCHEMBL27675445 0.90 AKR1C3 (0.61) AKR1C3MEN1KMT2AESR2SMN1; SMN2
Carbamic Acid SCHEMBL27693832 0.90 KMT2A (0.73) AKR1C3MEN1KMT2AESR2SMN1; SMN2
Carbamic Acid SCHEMBL28763111 0.87 LMNA (0.59) AKR1C3MEN1KMT2ASMN1; SMN2ALDH1A1
Carbamic Acid SCHEMBL4693159 0.87 AKR1C3 (0.58) AKR1C3MEN1KMT2AESR2SMN1; SMN2
SCHEMBL23081190 0.79 AKR1C3 (0.78) AKR1C3MEN1KMT2AESR2SMN1; SMN2
SCHEMBL693455 0.78 KMT2A (1.00) AKR1C3MEN1KMT2AESR2SMN1; SMN2
SCHEMBL29941108 0.76 KMT2A (0.82) AKR1C3MEN1KMT2AESR2SMN1; SMN2
SCHEMBL21067983 0.76 KMT2A (0.82) AKR1C3MEN1KMT2AESR2SMN1; SMN2
SCHEMBL20389408 0.76 KMT2A (0.77) AKR1C3MEN1KMT2AESR2SMN1; SMN2
Carbamic Acid SCHEMBL27675490 0.75 SMN1; SMN2 (0.54) AKR1C3MEN1KMT2ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101006059-A Substituted tetrahydroisoquinolines for use as MMP inhibitors, method for the production thereof, and use thereof in the form of medicaments SANOFI AVENTIS DEUTSCHLAND (DE) 2007-07-25 CN disclosed